In vitro and in vivo studies of ibuprofen-loaded biodegradable alginate beads

被引:64
作者
Arica, B
Çalis, S
Atilla, P
Durlu, NT
Çakar, N
Kas, HS
Hincal, AA
机构
[1] Univ Hacettepe, Fac Pharm, Dept Pharmaceut Technol, TR-06100 Ankara, Turkey
[2] Univ Hacettepe, Fac Med, Dept Histol & Embryol, TR-06100 Ankara, Turkey
[3] Univ Hacettepe, Fac Pharm, Dept Pharmacol, TR-06100 Ankara, Turkey
关键词
alginate beads; ibuprofen; microencapsulation; controlled release; gastric lesions;
D O I
10.1080/02652040400026319
中图分类号
O69 [应用化学];
学科分类号
081704 ;
摘要
The irritation effects of ibuprofen, a widely used non-steroidal anti-inflammatory drug ( NSAID), were evaluated on mouse gastric and duodenal mucosa when suspended in 0.5% (w/v) sodiumcarboxy-methylcellulose (NaCMC) solution and loaded in alginate beads. The ionotropic gelation method was used to prepare controlled release alginate beads of ibuprofen. The influence of various formulation factors on the encapsulation efficiency, as in vitro drug release and micromeritic properties, was investigated. Other variables included the alginate concentration, percentage drug loading and stirring speed during the microencapsulation process. Scanning electron micrographs of alginate beads loaded with ibuprofen showed rough surface morphology and particle sizes in the range of 1.15 +/- 0.4 - 3.15 +/- 0.6 mm. The yield of microspheres, as collected after drying, was generally 80 - 90%. Formulation code H showing t(50%) value of 3.5 h was chosen for in vivo trials because of the appropriate drug release properties. For in vivo trials, free ibuprofen ( 100 mg kg(-1)), blank and ibuprofen ( 100 mg kg(-1)) loaded alginate beads ( formulation code H) were suspended in 0.5% (w/v) NaCMC solution and each group was given to six mice orally by gavage. NaCMC solution was used as a control in experimental studies. In vivo data showed that the administration of ibuprofen in alginate beads prevented the gastric lesions.
引用
收藏
页码:153 / 165
页数:13
相关论文
共 25 条
[1]  
Acartürk F, 1999, J MICROENCAPSUL, V16, P291
[2]  
ACIKGOZ M, 1995, PHARMAZIE, V50, P275
[3]   DEVELOPMENT AND EVALUATION OF SUSTAINED-RELEASE IBUPROFEN-WAX MICROSPHERES .1. EFFECT OF FORMULATION VARIABLES ON PHYSICAL CHARACTERISTICS [J].
ADEYEYE, CM ;
PRICE, JC .
PHARMACEUTICAL RESEARCH, 1991, 8 (11) :1377-1383
[4]   5-fluorouracil encapsulated alginate beads for the treatment of breast cancer [J].
Arica, B ;
Çalis, S ;
Kas, HS ;
Sargon, MF ;
Hincal, AA .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2002, 242 (1-2) :267-269
[5]  
ARICA B, 2002, CHITOSAN PHARM CHEM, P71
[6]  
BAKAN JA, 1992, MICROCAPSULES NANOCA, P183
[7]   PREPARATION AND CHARACTERIZATION OF MICROOSPHERES CONTAINING THE ANTI-INFLAMMATORY AGENTS, INDOMETHACIN, IBUPROFEN, AND KETOPROFEN [J].
BODMEIER, R ;
CHEN, H .
JOURNAL OF CONTROLLED RELEASE, 1989, 10 (02) :167-175
[8]   MICROENCAPSULATION OF DRUGS WITH AQUEOUS COLLOIDAL POLYMER DISPERSIONS [J].
BODMEIER, R ;
WANG, JJ .
JOURNAL OF PHARMACEUTICAL SCIENCES, 1993, 82 (02) :191-194
[9]  
CALIS S, 2003, CONTR REL SOC 30 ANN, P495
[10]  
CALIS S, 2001, WORLD C PHARM PHARM, P81